TP53 and colorectal carcinoma: PIK3CA and TP53 mutations had no obvious effect on the prognosis of patients with CRC (PIK3CA: HR = 1.00, p = 0.985; TP53: HR = 1.02, p = 0.850) (Figures 1E, F).